These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. Plow E; Edgington TS J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160 [TBL] [Abstract][Full Text] [Related]
3. Molecular events responsible for modulation of neoantigenic expression: the cleavage-associated neoantigen of fibrinogen (blood coagulation-fibrinogen cleavage products-fibrinolysis-molecular conformation). Plow E; Edgington TS Proc Natl Acad Sci U S A; 1972 Jan; 69(1):208-12. PubMed ID: 4109598 [TBL] [Abstract][Full Text] [Related]
4. Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen. Marder VJ Scand J Haematol Suppl; 1971; 13():21-36. PubMed ID: 4258202 [No Abstract] [Full Text] [Related]
5. Independence of allotypic determinants and antibody specificity. Spring SB; Nisonoff A; Dray S J Immunol; 1970 Sep; 105(3):653-60. PubMed ID: 4195497 [No Abstract] [Full Text] [Related]
6. Isolation and some properties of fibrinogen from human blood platelets. Ganguly P J Biol Chem; 1972 Mar; 247(6):1809-16. PubMed ID: 4258978 [No Abstract] [Full Text] [Related]
7. Characterization of an immunoglobulin fragment in normal rat stools. Oriol R; Tolone G; Zweibaum A Prog Immunobiol Stand; 1970; 4():323-9. PubMed ID: 4098270 [No Abstract] [Full Text] [Related]
8. Immunochemistry of the thrombin-altered NH2-terminal disulfide knot of human fibrinogen. Qureshi GD; Butler VP; Harfenist EJ; Canfield RE; Nossel HL Thromb Res; 1975 Apr; 6(4):357-74. PubMed ID: 49088 [No Abstract] [Full Text] [Related]
9. The structure of the fibrinogen degradation products. Marder VJ; Budzynski AZ Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300 [No Abstract] [Full Text] [Related]
11. Studies on human secretory immunoglobulin A. II. Subunit structure. Mestecky J; Kulhavy R; Kraus FW J Immunol; 1972 Mar; 108(3):738-47. PubMed ID: 4110988 [No Abstract] [Full Text] [Related]
12. C3b inactivator of man. 3. Further purification and production of antibody to C3b INA. Ruddy S; Hunsicker LG; Austen KF J Immunol; 1972 Mar; 108(3):657-64. PubMed ID: 4622188 [No Abstract] [Full Text] [Related]
13. Effects of plasmin on human factor VIII (AHF). Pasquini R; Hershgold EJ Blood; 1973 Jan; 41(1):105-11. PubMed ID: 4118107 [No Abstract] [Full Text] [Related]
14. [Demonstration of antigenic determinants bound to the molecular structure in human gamma-G immunoglobulins]. Rivat C; Rivat L; Ropartz C Rev Fr Transfus; 1969; 12(1):Suppl:355-71. PubMed ID: 4193521 [No Abstract] [Full Text] [Related]
15. Platelet fibrinogen. Identity and initial observations on the mode of its degradation by plasmin. James HL; Bradford HR; Ganguly P Biochim Biophys Acta; 1975 Mar; 386(1):209-20. PubMed ID: 236019 [TBL] [Abstract][Full Text] [Related]
16. Immunochemistry and biochemistry of CEA. Mach JP; Holburn A Ann Immunol (Paris); 1973 Nov; 124(4):579-81. PubMed ID: 4134246 [No Abstract] [Full Text] [Related]
17. Immunoephelometric determination of fibrinogen and its derivatives in plasma. Farrell GW; Wolf P J Immunol Methods; 1972 May; 1(3):217-29. PubMed ID: 4116307 [No Abstract] [Full Text] [Related]
18. A rapid radioimmunoassay for measuring nanogram levels of antigens. Levin AS; Pipkins MO; Fudenberg HH Vox Sang; 1970 May; 18(5):459-66. PubMed ID: 4989306 [No Abstract] [Full Text] [Related]
19. The antigenic determinant of fibrin(ogen) measured with agglutination inhibition immunoassays. Molla A; Donati MB; Vermylen J J Clin Pathol; 1974 Jun; 27(6):473-9. PubMed ID: 4137968 [TBL] [Abstract][Full Text] [Related]